UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development

Cancer investigation, 2005, Vol.23 (3), p.264-273

2005

Volltextzugriff (PDF)

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

JAMA : the journal of the American Medical Association, 2006-04, Vol.295 (14), p.1658

2006

Volltextzugriff (PDF)

In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy : time to consider expanded clinical trials?

Leukemia, 2001-10, Vol.15 (10), p.1517-1520

2001

Volltextzugriff (PDF)

erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

JNCI : Journal of the National Cancer Institute, 1998-09, Vol.90 (18), p.1346-1360

1998

Volltextzugriff (PDF)

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer

Annals of oncology, 2002-06, Vol.13 (6), p.903-909

2002

Volltextzugriff (PDF)

The effect of antimicrotubule agents on signal transduction pathways of apoptosis : a review

Cancer chemotherapy and pharmacology, 1999, Vol.44 (5), p.355-361

1999

Volltextzugriff (PDF)

Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

JNCI : Journal of the National Cancer Institute, 1998-08, Vol.90 (16), p.1205-1211

1998

Volltextzugriff (PDF)

Identification of unique synergistic drug combinations associated with downexpression of survivin in a preclinical breast cancer model system

Anti-cancer drugs, 2012-03, Vol.23 (3), p.272-279

2012

Volltextzugriff (PDF)

Zoledronic Acid (Zometa®) Enhances the Cytotoxic Effect of Gemcitabine and Fluvastatin: In vitro Isobologram Studies with Conventional and Nonconventional Cytotoxic Agents

Oncology, 2006-01, Vol.70 (2), p.147-153

2006

Volltextzugriff (PDF)

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1795-1802

1998

Volltextzugriff (PDF)

In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia

Anti-cancer drugs, 2008-08, Vol.19 (7), p.705-712

2008

Volltextzugriff (PDF)

HER-2/neu and p53 Expression Versus Tamoxifen Resistance in Estrogen Receptor–Positive, Node-Positive Breast Cancer

Journal of clinical oncology, 2000-10, Vol.18 (20), p.3471-3479

2000

Volltextzugriff (PDF)

Abstract P2-09-09: The effects of treatment-induced symptoms, depression and age on sexuality in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-09-09

2017

Volltextzugriff (PDF)

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

The New England journal of medicine, 1994-05, Vol.330 (18), p.1260-1266

1994

Volltextzugriff (PDF)

Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma

Annals of oncology, 1999-01, Vol.10 (1), p.33-38

1999

Volltextzugriff (PDF)

Dose and schedule as determinants of outcomes in chemotherapy for breast cancer

Seminars in oncology, 2004-12, Vol.31 (6 Suppl 15), p.3-9

Budman, Daniel R.

2004

Volltextzugriff (PDF)

Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

The New England journal of medicine, 1994-05, Vol.330 (18), p.1253-1259

1994

Volltextzugriff (PDF)

In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines

Breast cancer research and treatment, 2002-07, Vol.74 (1), p.41-46

2002

Volltextzugriff (PDF)

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541

Journal of clinical oncology, 1996-11, Vol.14 (11), p.3000-3008

1996

Volltextzugriff (PDF)

P2-13-02: Parent of Origin of BRCA Mutation May Determine Age at Breast Cancer Diagnosis

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-13-02

2011

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of LY293111, an Orally Bioavailable LTB4 Receptor Antagonist, in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5365

2005

Volltextzugriff (PDF)

Studies of synergistic and antagonistic combinations of conventional cytotoxic agents with the multiple eicosanoid pathway modulator LY 293111

Anti-cancer drugs, 2004-10, Vol.15 (9), p.877-881

2004

Volltextzugriff (PDF)

Synergistic and antagonistic combinations of drugs in human prostate cancer cell lines in vitro

Anti-cancer drugs, 2002-11, Vol.13 (10), p.1011-1016

2002

Volltextzugriff (PDF)

Capecitabine

Investigational new drugs, 2000-11, Vol.18 (4), p.355-363

Budman, D R

2000

Volltextzugriff (PDF)

Vinorelbine (Navelbiner ): A Third-Generation Vinca Alkaloid

Cancer investigation, 1997, Vol.15 (5), p.475-490

Budman, Daniel R.

1997

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(110)
magazinearticle
(1)

Sprache

Englisch
(111)

Erscheinungsjahr

n.n

Thema

Science & Technology
(107)
Life Sciences & Biomedicine
(106)
Humans
(100)
Oncology
(76)
Female
(63)
Biological And Medical Sciences
(54)
Medical Sciences
(54)
Male
(53)
Middle Aged
(48)
Adult
(43)
Aged
(42)
Pharmacology. Drug Treatments
(40)
Antineoplastic Agents
(37)
Chemotherapy
(32)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Breast Neoplasms - Drug Therapy
(22)
Pharmacology & Pharmacy
(19)
Drug Evaluation
(18)
Drug Administration Schedule
(17)
Dose-Response Relationship, Drug
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy : time to consider expanded clinical trials?

erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer

The effect of antimicrotubule agents on signal transduction pathways of apoptosis : a review

Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

Identification of unique synergistic drug combinations associated with downexpression of survivin in a preclinical breast cancer model system

Zoledronic Acid (Zometa®) Enhances the Cytotoxic Effect of Gemcitabine and Fluvastatin: In vitro Isobologram Studies with Conventional and Nonconventional Cytotoxic Agents

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia

HER-2/neu and p53 Expression Versus Tamoxifen Resistance in Estrogen Receptor–Positive, Node-Positive Breast Cancer

Abstract P2-09-09: The effects of treatment-induced symptoms, depression and age on sexuality in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma

Dose and schedule as determinants of outcomes in chemotherapy for breast cancer

Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541

P2-13-02: Parent of Origin of BRCA Mutation May Determine Age at Breast Cancer Diagnosis

Phase I and Pharmacokinetic Study of LY293111, an Orally Bioavailable LTB4 Receptor Antagonist, in Patients With Advanced Solid Tumors

Studies of synergistic and antagonistic combinations of conventional cytotoxic agents with the multiple eicosanoid pathway modulator LY 293111

Synergistic and antagonistic combinations of drugs in human prostate cancer cell lines in vitro

Capecitabine

Vinorelbine (Navelbiner ): A Third-Generation Vinca Alkaloid

Suchergebnisse filtern